ClinicalTrials.gg
CompletedNCT04026295Updated Oct 29, 2026Results posted

Short-Burst Interval Treadmill Training Cerebral Palsy

An interventional study of Short Burst Interval Treadmill Training (SBLTT) and Traditional Locomotor Treadmill Training (TLTT) in Cerebral Palsy, sponsored by Kristie Bjornson. Completed at 2 sites in United States. Open to participants aged 6 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Kristie Bjornson · Not applicable, Interventional, and Treatment

How we know

Updated Oct 29, 2026Now CompletedResults posted+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
6 Years to 10 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 372 studies in Cerebral Palsy with a site in United States — 74 open to participants now, 102 under way, none of them phase 3. Cerebral Palsy · United States.

Enrollment
60th of 296
60 · median 25
Started
2019
with 19 others
No phase
218 of 372
49 open now
Registered
190th of 372
by date

Among the 372 studies in Cerebral Palsy with a site in United States, this one is the 60th largest by enrollment of the 296 interventional ones that give a count, is one of 20 that started in 2019, is one of 218 with no phase, and was the 190th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

74 of the 372 studies in Cerebral Palsy with a site in United States are open now. Recruiting first, the newest first:

69 more — sign in →

All 74 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 6 Years to 10 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 372 studies in Cerebral Palsy with a site in United States, or all of them as a file.
02

Study summary

Ambulatory children with cerebral palsy (CP) walk predominately in low intensity stride rates with little variability, thus limiting their walking activity and ability to participate in daily life. In contrast, typically developing (TD) children engage in short bursts of intense walking activity interspersed with varying intervals of low intensity walking within daily life. In order to optimize motor learning, active participation, task-specific training and multiple repetitions or massed practice is required to learn new motor skills. Short bursts of vigorous intensity locomotor treadmill training (SBLTT) alternating with low/moderate intensity was specifically designed to mimic activity patterns of TD children in a massed practice format. Pilot data suggests that SBLTT is feasible and enhances walking capacity and performance in daily life for children with CP. This project will examine the effect of SBLTT versus an equivalent dosage of traditional locomotor treadmill training (TLTT) on the primary outcomes of walking capacity and performance in children with CP and whether the effects of SBLTT on walking capacity and performance are mediated by improvements in in muscle power generation. The scientific premise is that SBLTT, that approximates the walking intensity patterns of typically developing (TD) children through a home-based massed practice protocol, will be more effective than TLTT in improving walking capacity and performance. We hypothesize that SBLTT strategies for children with CP modeled on walking patterns of TD children, will be positively mediated by muscle power generation and subsequently improve walking capacity and community walking performance and mobility. Specific aims. Aim #1. Determine the immediate and retention effects of short-burst interval LTT (SBLTT) on walking capacity in ambulatory children with CP. Aim #2. Examine the effects of treatment on community-based walking activity performance and mobility. Aim #3. Explore whether the effects of SBLTT on walking capacity and performance are mediated by muscle power generation. The proposed research will be the first step in a continuum of research that is expected to direct locomotor training protocols and rehab strategies across pediatric disabilities and positively effecting the community walking performance and mobility for children with CP.

Read the detailed description

In a randomized clinical trial, 72 ambulatory children with spastic CP (6-10 yrs.) will receive either SBLTT or an equivalent dosage of TLTT for 40 sessions, 5x/week for 8 weeks in a massed practice format. The only difference between training protocols will be the variable training (interval fast versus steady state walking speeds). Thus, the key ingredient will be the intensity of the interval training delivered in a serial blocked practice schedule. Outcomes will be collected at baseline, 4 and 8 weeks to assess dosage, and 24 weeks post training for long term retention with the primary endpoint at 8 weeks.

03

Conditions studied

  • Cerebral Palsy

Keywords

  • treadmill training
  • gait
  • short burst interval locomotor training
  • spastic
04

Who can participate

Ages eligible
6 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Bilateral and unilateral spastic cerebral palsy
  • Gross Motor Function Classification Levels II \& III
  • Ages 6 years to \< 11 years

Exclusion criteria

Exclusion Criteria:

  • Orthopedic or neurosurgery \< 9 months prior
  • Injection therapy (Botulinum Toxin/Phenol) \< 3 months prior
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Short burst Interval Treadmill Training (SBLTT)

    SBLTT will consist of short-bursts (30 seconds) of high speed walking alternating with 30 seconds of low/moderate speed walking. Participant will receive 40 home-based sessions (5x/week for 8 weeks) of SBLTT

    Behavioral: Short Burst Interval Treadmill Training (SBLTT)

  • Active comparator
    Traditional Locomotor Treadmill Training (TLTT)

    TLTT will consist of walking at steady-state speeds. Participant will receive 40 home-based sessions (5x/week for 8 weeks) of TLTT

    Behavioral: Traditional Locomotor Treadmill Training (TLTT)

Interventions

  • BehavioralShort Burst Interval Treadmill Training (SBLTT)

    SBLTT will consist of short-bursts (30 seconds) of high speed walking alternating with 30 seconds of low/moderate speed walking. Total duration of walking per session will be up to 30 minutes of the 30 second alternating intervals (30sec high / 30sec low/moderate) with rests as needed. Both groups will receive 40 sessions delivered 5x/week for 8 weeks. Initial speeds for high speed walking will be 75-80% of each participant's over ground baseline fast walking speed, and low/moderate speed will be 75-80% of self-selected speed calculated from the 10-Meter Walk Test.

  • BehavioralTraditional Locomotor Treadmill Training (TLTT)

    TLTT group will receive the same number of sessions (40) delivered 5x/week for 8 weeks with a total duration of walking per session up to 30 minutes with rests as needed. TLTT will consist of walking at steady-state speeds. Initial treadmill speed will be 75-80% of over ground self-selected walking speed. The overall goal will be to achieve 30 minutes of walking at a steady-state walking speed within each session. Speed will be increased on the next session by .1 to .4mph when the subject can walk for 30 minutes on the treadmill at the current speed with an OMNI score of \< 6/10.

06

What researchers measure

Primary outcomes

  1. Change in Walking Capacity-Self-selected Walking Speed (Normalized)

    Normalized 10 Meter Walk Test in meters/second. Calculated from the 10-meter walk test in meters/second at self-selected speed and then normalized by the following formula: velocity / square root (9.81 x leg length) yielding non-dimensional units. Higher values represent faster gait speeds.

    Time frame: Baseline to 8 weeks

  2. Change in Walking Capacity-Fast Walking Speed (Normalized)

    Calculated from the 10-meter walk test in meters/second at fast walking speed and then normalized by the following formula: velocity / square root (9.81 x leg length) yielding non-dimensional units. Higher values represent faster gait speeds.

    Time frame: Baseline to 8 weeks

  3. Change in One Minute Walk Test

    Distance covered while walking as fast as possible for 1 minute measured in meters

    Time frame: Baseline to 8 weeks

  4. Change in Average Strides Per Day

    Average number of strides walked per day captured by Step Watch accelerometer as worn for a minimum of 4 days.

    Time frame: Baseline to 8 weeks

  5. Absolute Change in Percent Strides/Day in Medium/High Stride Rates

    StepWatch (SW) accelerometry - percent of strides/day in medium/high stride rates (\> 30 strides/minute). Calculated as percentage value at 8 weeks minus the percentage value at baseline.

    Time frame: Baseline to 8 weeks

  6. Change in Right Knee Extensor Muscle Power

    Isokinetic dynamometer (Biodex System 3/4) according to published standard procedures for isokinetic power. Calculated for right knee extensors at 60 degrees/second in watts.

    Time frame: Baseline to 8 weeks.

  7. Change in Left Knee Extensor Muscle Power

    Isokinetic dynamometer (Biodex System 3/4) according to published standard procedures for isokinetic power. Calculated for left knee extensors at 60 degrees/second in watts.

    Time frame: Baseline to 8 weeks

Secondary outcomes

  1. Change in Average Strides Per Day in the Home.

    StepWatch (SW) accelerometry strides/day synchronized with Global Positioning System (GPS) home location setting- average strides per day.

    Time frame: Baseline to 8 weeks

  2. Absolute Change in Percent Average Strides/Day in the Community.

    StepWatch (SW) accelerometry synchronized with Global Positioning System (GPS) home setting- percent average strides/day in the community. Calculated as percentage value at 8 weeks minus the percentage value at baseline.

    Time frame: Baseline to 8 weeks

  3. Change in PROMIS Physical Function Domain Score -

    Patient-Reported Outcomes Measurement Information System (PROMIS v1.0 Parent Pediatric Profile) physical function domain score T scores, Mean of 50 and standard deviation of 10. Higher is a better report of physical function.

    Time frame: Baseline to 8 weeks

  4. Change in Gait Outcomes Assessment List (GOAL) Total Score

    Parent report Gait Outcome Assessment List (GOAL).total score scale 0-10 with higher score better parent report of gait walking skills and mobility.

    Time frame: Baseline to 8 weeks

  5. Change in Right Knee Peak Extensor Muscle Torque (Normalized).

    Isokinetic Peak Torque for right knee extensors at 60 deg/s as measured by Biodex normalized by kg/weight.

    Time frame: Baseline to 8 weeks.

  6. Absolute Change in Percent Average Strides/Day in Medium/High Activity in the Home.

    StepWatch (SW) accelerometry synchronized (average strides/day) with Global Positioning System (GPS) home setting- percent average strides/day in medium/high stride rates (\>30 strides/minute). Calculated as percentage value at 8 weeks minus the percentage value at baseline.

    Time frame: Baseline to 8 weeks

  7. Absolute Change in Percent Average Strides/Day at Medium/High Stride Rates in the Community

    StepWatch (SW) accelerometry synchronized with Global Positioning System (GPS) community setting- percent average strides/day at medium/high stride rates (\>30 strides/minute). Calculated as percentage value at 8 weeks minus the percentage value at baseline.

    Time frame: Baseline to 8 weeks

  8. Change in Left Knee Peak Extensor Muscle Torque (Normalized).

    Isokinetic Peak Torque for Left knee extensors at 60 deg/s as measured by Biodex normalized by kg/weight.

    Time frame: Baseline to 8 weeks

07

Results

Posted Oct 29, 2026

Participant flow

Participant flow — Overall Study
MilestoneShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Started2832
Completed2429
Not completed43

Outcome measures

PrimaryChange in Walking Capacity-Self-selected Walking Speed (Normalized)

Normalized 10 Meter Walk Test in meters/second. Calculated from the 10-meter walk test in meters/second at self-selected speed and then normalized by the following formula: velocity / square root (9.81 x leg length) yielding non-dimensional units. Higher values represent faster gait speeds.

Time frame:
Baseline to 8 weeks
Reported as:
Mean · Unitless
Change in Walking Capacity-Self-selected Walking Speed (Normalized)
UnitlessShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Change in Walking Capacity-Self-selected Walking Speed (Normalized)0.03 ± 0.050.01 ± 0.04
PrimaryChange in Walking Capacity-Fast Walking Speed (Normalized)

Calculated from the 10-meter walk test in meters/second at fast walking speed and then normalized by the following formula: velocity / square root (9.81 x leg length) yielding non-dimensional units. Higher values represent faster gait speeds.

Time frame:
Baseline to 8 weeks
Reported as:
Mean · Unitless
Change in Walking Capacity-Fast Walking Speed (Normalized)
UnitlessShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Change in Walking Capacity-Fast Walking Speed (Normalized)0.04 ± 0.070.02 ± 0.04
PrimaryChange in One Minute Walk Test

Distance covered while walking as fast as possible for 1 minute measured in meters

Time frame:
Baseline to 8 weeks
Reported as:
Mean · Distance in Meters
Change in One Minute Walk Test
Distance in MetersShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Change in One Minute Walk Test7.95 ± 16.457.9 ± 10.97
PrimaryChange in Average Strides Per Day

Average number of strides walked per day captured by Step Watch accelerometer as worn for a minimum of 4 days.

Time frame:
Baseline to 8 weeks
Reported as:
Mean · Average strides per day
Change in Average Strides Per Day
Average strides per dayShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Change in Average Strides Per Day-168.65 ± 1855.71-143.85 ± 1389.55
PrimaryAbsolute Change in Percent Strides/Day in Medium/High Stride Rates

StepWatch (SW) accelerometry - percent of strides/day in medium/high stride rates (\> 30 strides/minute). Calculated as percentage value at 8 weeks minus the percentage value at baseline.

Time frame:
Baseline to 8 weeks
Reported as:
Mean · Absolute change in percent
Absolute Change in Percent Strides/Day in Medium/High Stride Rates
Absolute change in percentShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Absolute Change in Percent Strides/Day in Medium/High Stride Rates-0.24 ± 9.21-0.55 ± 10.48
PrimaryChange in Right Knee Extensor Muscle Power

Isokinetic dynamometer (Biodex System 3/4) according to published standard procedures for isokinetic power. Calculated for right knee extensors at 60 degrees/second in watts.

Time frame:
Baseline to 8 weeks.
Reported as:
Mean · Watts
Change in Right Knee Extensor Muscle Power
WattsShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Change in Right Knee Extensor Muscle Power-0.07 ± 0.170.01 ± 0.13
SecondaryChange in Average Strides Per Day in the Home.

StepWatch (SW) accelerometry strides/day synchronized with Global Positioning System (GPS) home location setting- average strides per day.

Time frame:
Baseline to 8 weeks
Reported as:
Mean · Strides/day in Home location
Change in Average Strides Per Day in the Home.
Strides/day in Home locationShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Change in Average Strides Per Day in the Home.-133.45 ± 1289.88-245.96 ± 897.9
SecondaryAbsolute Change in Percent Average Strides/Day in the Community.

StepWatch (SW) accelerometry synchronized with Global Positioning System (GPS) home setting- percent average strides/day in the community. Calculated as percentage value at 8 weeks minus the percentage value at baseline.

Time frame:
Baseline to 8 weeks
Reported as:
Mean · Absolute percent change
Absolute Change in Percent Average Strides/Day in the Community.
Absolute percent changeShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Absolute Change in Percent Average Strides/Day in the Community.-591.07 ± 760.98202.71 ± 1029.43
SecondaryChange in PROMIS Physical Function Domain Score -

Patient-Reported Outcomes Measurement Information System (PROMIS v1.0 Parent Pediatric Profile) physical function domain score T scores, Mean of 50 and standard deviation of 10. Higher is a better report of physical function.

Time frame:
Baseline to 8 weeks
Reported as:
Mean · standard score
Change in PROMIS Physical Function Domain Score -
standard scoreShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Change in PROMIS Physical Function Domain Score -3.15 ± 4.332.03 ± 2.7
SecondaryChange in Gait Outcomes Assessment List (GOAL) Total Score

Parent report Gait Outcome Assessment List (GOAL).total score scale 0-10 with higher score better parent report of gait walking skills and mobility.

Time frame:
Baseline to 8 weeks
Reported as:
Mean · GOAL total standard score
Change in Gait Outcomes Assessment List (GOAL) Total Score
GOAL total standard scoreShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Change in Gait Outcomes Assessment List (GOAL) Total Score8.89 ± 9.485.11 ± 8.08
SecondaryChange in Right Knee Peak Extensor Muscle Torque (Normalized).

Isokinetic Peak Torque for right knee extensors at 60 deg/s as measured by Biodex normalized by kg/weight.

Time frame:
Baseline to 8 weeks.
Reported as:
Mean · Newton Meters/kg
Change in Right Knee Peak Extensor Muscle Torque (Normalized).
Newton Meters/kgShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Change in Right Knee Peak Extensor Muscle Torque (Normalized).-0.18 ± 0.32-0.08 ± 0.26
SecondaryAbsolute Change in Percent Average Strides/Day in Medium/High Activity in the Home.

StepWatch (SW) accelerometry synchronized (average strides/day) with Global Positioning System (GPS) home setting- percent average strides/day in medium/high stride rates (\>30 strides/minute). Calculated as percentage value at 8 weeks minus the percentage value at baseline.

Time frame:
Baseline to 8 weeks
Reported as:
Mean · absolute change in percent
Absolute Change in Percent Average Strides/Day in Medium/High Activity in the Home.
absolute change in percentShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Absolute Change in Percent Average Strides/Day in Medium/High Activity in the Home.0 ± 0.120 ± 0.07
SecondaryAbsolute Change in Percent Average Strides/Day at Medium/High Stride Rates in the Community

StepWatch (SW) accelerometry synchronized with Global Positioning System (GPS) community setting- percent average strides/day at medium/high stride rates (\>30 strides/minute). Calculated as percentage value at 8 weeks minus the percentage value at baseline.

Time frame:
Baseline to 8 weeks
Reported as:
Mean · absolute change in percent
Absolute Change in Percent Average Strides/Day at Medium/High Stride Rates in the Community
absolute change in percentShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Absolute Change in Percent Average Strides/Day at Medium/High Stride Rates in the Community-0.02 ± 0.130.04 ± 0.14
PrimaryChange in Left Knee Extensor Muscle Power

Isokinetic dynamometer (Biodex System 3/4) according to published standard procedures for isokinetic power. Calculated for left knee extensors at 60 degrees/second in watts.

Time frame:
Baseline to 8 weeks
Reported as:
Mean · Watts
Change in Left Knee Extensor Muscle Power
WattsShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Change in Left Knee Extensor Muscle Power0.01 ± 0.17-0.01 ± 0.11
SecondaryChange in Left Knee Peak Extensor Muscle Torque (Normalized).

Isokinetic Peak Torque for Left knee extensors at 60 deg/s as measured by Biodex normalized by kg/weight.

Time frame:
Baseline to 8 weeks
Reported as:
Mean · Newton Meters/kg
Change in Left Knee Peak Extensor Muscle Torque (Normalized).
Newton Meters/kgShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
Change in Left Knee Peak Extensor Muscle Torque (Normalized).-0.01 ± 0.320 ± 0.21

Adverse events

Collected over From baseline until end of follow-up, up to training session, up to 28 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Short Burst Interval Treadmill Training (SBLTT)0/28 (0%)2/28 (7.1%)16/28 (57.1%)
Traditional Locomotor Treadmill Training (TLTT)0/32 (0%)0/32 (0%)16/32 (50%)
Most frequent serious events
Most frequent serious events
EventShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
diabetes onset (not related to the study)Endocrine disorders1/280/32
tonsil surgery (not related to the study)Surgical and medical procedures1/280/32
Most frequent other events
Showing 10 of 17
Most frequent other events
EventShort Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)
foot painMusculoskeletal and connective tissue disorders1/285/32
Influenza-like illnessGeneral disorders0/284/32
broken orthoticProduct Issues3/280/32
nausea/vomitingGastrointestinal disorders3/282/32
COVID-19-related eventGeneral disorders3/282/32
skin blisterSkin and subcutaneous tissue disorders3/283/32
knee painMusculoskeletal and connective tissue disorders1/283/32
Seizure-like activityNervous system disorders2/281/32
headacheNervous system disorders0/282/32
muscle cramp/soreness/spasmMusculoskeletal and connective tissue disorders1/282/32

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Short Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)Total
Mean8.26 ± 1.708.48 ± 1.468.34 ± 1.58
Age, Customized
Age, Customized(Participants)Short Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)Total
6.0 to 8.4 years171633
8.5 to 11 years111627
Sex: Female, Male
Sex: Female, Male(Participants)Short Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)Total
Female81523
Male201737
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Short Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)Total
American Indian or Alaska Native101
Asian314
Native Hawaiian or Other Pacific Islander000
Black or African American347
White151833
More than one race4812
Unknown or Not Reported213
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Short Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)Total
Hispanic or Latino437
Not Hispanic or Latino242953
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Short Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)Total
United States283260
Gross Motor Function Classification System (GMFCS)
Gross Motor Function Classification System (GMFCS)(Participants)Short Burst Interval Treadmill Training (SBLTT)Traditional Locomotor Treadmill Training (TLTT)Total
GMFCS Level I4610
GMFCS Level II202242
GMFCS Level III448
08

Study locations

2 sites
  • Lousianna State University Health Sciences Center New Orleans
    New Orleans, Louisiana 70112, United States
  • Seattle Childrens Research Institute
    Seattle, Washington 98121, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2019 to primary completion in Aug 2025, 68 months.

Results were first posted in Oct 2026, 1 year 2 months after primary completion.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's 68 months is above that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 29, 2026: primary completion Jun 2025 → Aug 2025 and completion Aug 2025 → Aug 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 17, 2019
First posted
Jul 19, 2019
StartActual
Nov 27, 2019
Primary completionActual
Aug 1, 2025was Jun 2025
CompletionActual
Aug 31, 2026was Aug 2025
Results first posted
Oct 29, 2026
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Oct 29, 2026
Results
Results posted
posted Oct 29, 2026
Primary completion
Jun 1, 2025→Aug 1, 2025
Oct 29, 2026
Study completion
Aug 31, 2025→Aug 31, 2026 (actual)
Oct 29, 2026
Primary outcomes
3 edited, 4 added, 3 removed
What changed in the outcomes
  • EditedChange in Walking Capacity-Self-selected walking speedWalking Speed (Normalized)Time frame: Baseline to 8 weeks
  • EditedChange in Walking Capacity-Fast walking speedWalking Speed (Normalized)Time frame: Baseline to 8 weeks
  • EditedChange in Right Knee extensor muscle powerExtensor Muscle PowerTime frame: Baseline to 8 weeks.
  • AddedChange in One Minute Walk TestTime frame: Baseline to 8 weeks
  • AddedChange in Average Strides Per DayTime frame: Baseline to 8 weeks
  • AddedAbsolute Change in Percent Strides/Day in Medium/High Stride RatesTime frame: Baseline to 8 weeks
  • AddedChange in Left Knee Extensor Muscle PowerTime frame: Baseline to 8 weeks
  • RemovedWalking Capacity-EnduranceTime frame: Baseline to 8 weeks
  • RemovedWalking Performance-levelTime frame: Baseline to 8 weeks
  • RemovedWalking Performance-IntensityTime frame: Baseline to 8 weeks
Oct 29, 2026
Documents
Secondary outcomes
1 edited, 7 added, 6 removed
What changed in the outcomes
  • EditedChange in Right Knee extensor muscle torquePeak Extensor Muscle Torque (Normalized).Time frame: Baseline to 8 weeks.
  • AddedChange in Average Strides Per Day in the Home.Time frame: Baseline to 8 weeks
  • AddedAbsolute Change in Percent Average Strides/Day in the Community.Time frame: Baseline to 8 weeks
  • AddedChange in PROMIS Physical Function Domain Score -Time frame: Baseline to 8 weeks
  • AddedChange in Gait Outcomes Assessment List (GOAL) Total ScoreTime frame: Baseline to 8 weeks
  • AddedAbsolute Change in Percent Average Strides/Day in Medium/High Activity in the Home.Time frame: Baseline to 8 weeks
  • AddedAbsolute Change in Percent Average Strides/Day at Medium/High Stride Rates in the CommunityTime frame: Baseline to 8 weeks
  • AddedChange in Left Knee Peak Extensor Muscle Torque (Normalized).Time frame: Baseline to 8 weeks
  • RemovedWalking Mobility -level homeTime frame: Baseline to 8 weeks
  • RemovedWalking Mobility-intensity homeTime frame: Baseline to 8 weeks
  • RemovedMobility-Patient Reported OutcomeTime frame: Baseline to 8 weeks
  • RemovedFamily Gait Priorities and Quality of gaitTime frame: Baseline to 8 weeks
  • RemovedWalking Mobility-intensity communityTime frame: Baseline to 8 weeks
  • RemovedWalking Mobility -level communityTime frame: Baseline to 8 weeks
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    Active, not recruiting→Completed
    Results posted
    Primary completion Jun 1, 2025→Aug 1, 2025
    Study completion Aug 31, 2025→Aug 31, 2026 (now actual)
    Primary outcomes 3 edited, 4 added, 3 removed
    What changed in the outcomes
    • EditedChange in Walking Capacity-Self-selected walking speedWalking Speed (Normalized)Time frame: Baseline to 8 weeks
    • EditedChange in Walking Capacity-Fast walking speedWalking Speed (Normalized)Time frame: Baseline to 8 weeks
    • EditedChange in Right Knee extensor muscle powerExtensor Muscle PowerTime frame: Baseline to 8 weeks.
    • AddedChange in One Minute Walk TestTime frame: Baseline to 8 weeks
    • AddedChange in Average Strides Per DayTime frame: Baseline to 8 weeks
    • AddedAbsolute Change in Percent Strides/Day in Medium/High Stride RatesTime frame: Baseline to 8 weeks
    • AddedChange in Left Knee Extensor Muscle PowerTime frame: Baseline to 8 weeks
    • RemovedWalking Capacity-EnduranceTime frame: Baseline to 8 weeks
    • RemovedWalking Performance-levelTime frame: Baseline to 8 weeks
    • RemovedWalking Performance-IntensityTime frame: Baseline to 8 weeks
    Secondary outcomes 1 edited, 7 added, 6 removed
    What changed in the outcomes
    • EditedChange in Right Knee extensor muscle torquePeak Extensor Muscle Torque (Normalized).Time frame: Baseline to 8 weeks.
    • AddedChange in Average Strides Per Day in the Home.Time frame: Baseline to 8 weeks
    • AddedAbsolute Change in Percent Average Strides/Day in the Community.Time frame: Baseline to 8 weeks
    • AddedChange in PROMIS Physical Function Domain Score -Time frame: Baseline to 8 weeks
    • AddedChange in Gait Outcomes Assessment List (GOAL) Total ScoreTime frame: Baseline to 8 weeks
    • AddedAbsolute Change in Percent Average Strides/Day in Medium/High Activity in the Home.Time frame: Baseline to 8 weeks
    • AddedAbsolute Change in Percent Average Strides/Day at Medium/High Stride Rates in the CommunityTime frame: Baseline to 8 weeks
    • AddedChange in Left Knee Peak Extensor Muscle Torque (Normalized).Time frame: Baseline to 8 weeks
    • RemovedWalking Mobility -level homeTime frame: Baseline to 8 weeks
    • RemovedWalking Mobility-intensity homeTime frame: Baseline to 8 weeks
    • RemovedMobility-Patient Reported OutcomeTime frame: Baseline to 8 weeks
    • RemovedFamily Gait Priorities and Quality of gaitTime frame: Baseline to 8 weeks
    • RemovedWalking Mobility-intensity communityTime frame: Baseline to 8 weeks
    • RemovedWalking Mobility -level communityTime frame: Baseline to 8 weeks
    + 2 other changes: verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04026295
Lead sponsor
Kristie Bjornson
Collaborators
University of Washington, Louisiana State University Health Sciences Center in New Orleans
Responsible party
Kristie Bjornson (Professor, Pediatrics, Seattle Children's Hospital) — Sponsor-investigator
First posted
Jul 19, 2019
Start date
Nov 27, 2019
Primary completion
Aug 1, 2025
Completion
Aug 31, 2026
Results posted
Oct 29, 2026
Last update
Oct 29, 2026

Study contacts

Kristie F Bjornson, PhD, PT
principal investigator · Seattle Children's Hospital
Noelle Moreau, PhD, PT
principal investigator · Lousianna State University in New Orleans

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion